The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab (the TezEx Study): a Retrospective and Prospective Observational Study
Latest Information Update: 06 Nov 2024
Price :
$35 *
At a glance
- Drugs Tezepelumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms The TezEx Study
- 06 Nov 2024 New trial record